Filing Details

Accession Number:
0000899243-18-029481
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-20 17:12:16
Reporting Period:
2018-11-16
Accepted Time:
2018-11-20 17:12:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1253176 Vapotherm Inc VAPO Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420106 B.v. Holding Healthcare Gilde Newtonlaan 91 3584 Bp Utrecht
The Netherlands
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-16 1,028,079 $0.00 1,028,079 No 4 C Indirect See Footnote
Common Stock Acquisiton 2018-11-16 68,447 $0.00 1,096,526 No 4 C Indirect See Footnote
Common Stock Acquisiton 2018-11-16 92,500 $14.00 1,189,026 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Convertible Preferred Stock Disposition 2018-11-16 482,142 $0.00 482,142 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2018-11-16 401,527 $0.00 401,527 $0.00
Common Stock Series D Convertible Preferred Stock Disposition 2018-11-16 144,410 $0.00 144,410 $0.00
Common Stock Series D-1 Convertible Preferred Stock Disposition 2018-11-16 68,447 $0.00 68,447 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Upon closing of the Issuer's initial public offering, each share of Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series D Convertible Preferred Stock automatically converted into one share of Common Stock without payment or further consideration. There was no expiration date for the Series B Convertible Preferred Stock, the Series C Convertible Preferred Stock or the Series D Convertible Preferred Stock.
  2. Upon closing of the Issuer's initial public offering, each share of Series D-1 Convertible Preferred Stock automatically converted into 1.137 shares of Common Stock without payment or further consideration. There was no expiration date for the Series D-1 Convertible Preferred Stock.
  3. The shares are held directly by Cooperatieve Gilde Healthcare III Sub-Holding U.A. ("Gilde"). Geoff Pardo ("Pardo"), who is a member of the Issuer's board of directors, is a partner of Gilde. Gilde is managed by Gilde Healthcare III Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Pardo, Management and Holding may be deemed to have voting, investment and dispositive power with respect to these securities. Each of Pardo, Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein